Correlation Between Sangamo Therapeutics and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Sangamo Therapeutics and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Rigel Pharmaceuticals.
Diversification Opportunities for Sangamo Therapeutics and Rigel Pharmaceuticals
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sangamo and Rigel is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and Rigel Pharmaceuticals
Given the investment horizon of 90 days Sangamo Therapeutics is expected to generate 3.31 times less return on investment than Rigel Pharmaceuticals. But when comparing it to its historical volatility, Sangamo Therapeutics is 1.07 times less risky than Rigel Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest 1,434 in Rigel Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 1,354 from holding Rigel Pharmaceuticals or generate 94.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sangamo Therapeutics vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Sangamo Therapeutics |
| Rigel Pharmaceuticals |
Sangamo Therapeutics and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sangamo Therapeutics and Rigel Pharmaceuticals
The main advantage of trading using opposite Sangamo Therapeutics and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Sangamo Therapeutics vs. Bright Minds Biosciences | Sangamo Therapeutics vs. HP Inc | Sangamo Therapeutics vs. Intel | Sangamo Therapeutics vs. Chevron Corp |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |